BUD13: A Protein Involved in Neurological Disorders (G84811)

Target Name: BUD13

NCBI ID: G84811

BUD13

BUD13: A Protein Involved in Neurological Disorders

BUD13 is a protein that is expressed in the brain and is known for its role in the development and progression of various neurological disorders, including Alzheimer's disease. The protein is named after Dr. Barbara Wu Zhongbin (Bud13), a renowned researcher at the University of California, San Diego, who first identified the protein in the brain.

BUD13 is a transmembrane protein that is expressed in the brain and is involved in a wide range of physiological processes, including cell signaling, neurotransmitter release, and synaptic plasticity. It is a key regulator of the microtubules, which are the structural elements that provide stability and mechanical forces to the brain cells.

One of the most significant functions of BUD13 is its role in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time. BUD13 is involved in the formation and maintenance of long-term synaptic plasticity, as well as the regulation of short-term synaptic plasticity.

BUD13 is also involved in the regulation of neurotransmitter release, which is the process by which neurotransmitters are released from neurons into the synaptic cleft, thereby realizing the transmission of nerve signals. Research shows that BUD13 plays a key role in transmitting neurotransmitters between neurons.

In addition, BUD13 is also involved in the regulation of cell signaling. In the process of transmitting signals between neurons, BUD13 regulates the electrical signal transmission between neurons by regulating the open state of ion channels.

BUD13 is a protein that plays an important role in the nervous system. BUD13 plays a key role in the nervous system by participating in the regulation of cell signaling, neurotransmitter release, and cell morphology. Therefore, BUD13 is a potential drug target that may be used to treat various neurological diseases in the future.

Protein Name: BUD13 Homolog

Functions: Involved in pre-mRNA splicing as component of the activated spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable)

The "BUD13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BUD13 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets